BackOscar Health Overview
Oscar Health Inc - Ordinary Shares - Class A

Oscar Health Target Price

See Oscar Health's analyst price targets ($35) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$30.94

Average Target Price

$34.8512.6% upside

13 analysts in the last 4 months

High: $49 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-18Raymond James$4235.7% upsideOpen
2026-09-17Piper SandlerJessica Tassan$4855.1% upsideOpen
2026-09-17Robert W. BairdMichael Ha$336.7% upsideOpen
2026-09-17Goldman SachsScott Fidel$349.9% upsideOpen
2026-09-17BarclaysAndrew Mok$4958.4% upsideOpen
2026-09-17UBS$303% downsideOpen
2026-08-11Goldman Sachs$303% downsideOpen
2026-08-07Robert W. Baird$2712.7% downsideOpen
2026-08-06BarclaysAndrew Mok$3926.1% upsideOpen
2026-07-28Piper Sandler$3616.4% upsideOpen
2026-06-15Raymond JamesJohn Ransom$303% downsideOpen
2026-06-10BarclaysAndrew Mok$3513.1% upsideOpen
2026-06-04Wells FargoStephen Baxter$2035.4% downsideOpen
2026-05-26Barclays$303% downsideOpen
2026-05-07UBSJonathan Yong$2035.4% downsideOpen
2026-05-07Barclays$2132.1% downsideOpen
2026-04-20JefferiesDavid Windley$1648.3% downsideOpen
2026-02-12Raymond James$1841.8% downsideOpen
2026-02-11UBSJonathan Yong$1551.5% downsideOpen
2026-01-09UBS$1745.1% downsideOpen
2026-01-05BarclaysAndrew Mok$1841.8% downsideOpen
2025-10-14Goldman Sachs$1745.1% downsideOpen
2025-10-07Wells Fargo$1454.8% downsideOpen
2025-08-14Piper SandlerJessica Tassan$1358% downsideOpen
2024-08-08Piper SandlerJessica Tassan$289.5% downsideOpen
2024-06-25Piper SandlerJessica Tassan$2519.2% downsideOpen
2024-06-12Wells FargoStephen Baxter$2712.7% downsideOpen
2024-06-10Goldman SachsNathan Rich$2132.1% downsideOpen
2024-03-21Raymond JamesJohn Ransom$2035.4% downsideOpen
2022-11-15Wells FargoStephen Baxter$487.1% downsideOpen
2022-11-14Morgan Stanley$583.8% downsideOpen
2022-09-01Morgan Stanley$970.9% downsideOpen
2022-06-09Morgan Stanley$1261.2% downsideOpen

Oscar Health (OSCR) FAQ

Oscar Health posts a target price of $35. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $35 for OSCR means covering analysts, on average, see the stock 12.6% upside of $30.94 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for OSCR's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Oscar Health's other metric pages and overview cover the third.

Judging Oscar Health against Finance peers is usually better than using a market-wide rule of thumb. Business models inside Finance are more comparable, which makes gaps in target price easier to interpret. Start with $35 here, then scan peer and history charts to see if the gap is persistent.